Education
About Us
Working with TipRanks
Follow Us
ALK-abello A/S Class B (AKBLF)
OTHER OTC:AKBLF
Earnings Data
Report Date
Feb 05, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
―Last Year’s EPS
0.12Same Quarter Last Year
Moderate Buy
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance, successful product launches, and strategic partnerships, contributing to growth across regions. However, challenges remain in some markets and with traditional product competition, impacting costs.Company Guidance
Strong Financial Performance
Revenue grew by 18% and earnings were up 41% in local currencies, yielding an EBIT margin of 28%. The full-year revenue growth is expected to be 13% to 15%, with an EBIT margin increase to approximately 26%.
Successful Pediatric Tablet Launches
The rollout of the house dust mite tablet, ACARIZAX, and the tree tablet, ITULAZAX, for children progressed well, contributing to the inflow of new patients and attracting new prescribers.
Partnership in China
ALK entered a partnership with GenSci in China to accelerate the uptake of house dust mite allergy products. The partnership is expected to be margin accretive, with potential payments up to DKK 1.3 billion.
Neffy Launch in Europe
EURneffy, the adrenaline spray, gained traction in Germany and was introduced in the U.K., indicating long-term potential despite challenges.
Growth Across Regions
Europe reported 18% growth, North America 20%, and international markets 14%, driven by strong tablet sales and the anaphylaxis portfolio.
Improved Cash Flow and Debt Position
Free cash flow almost doubled to DKK 836 million, and the net debt-to-EBITDA ratio is now at minus 0.1, indicating no debt.
AKBLF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
AKBLF Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 12, 2025 | $32.00 | $33.05 | +3.28% |
Aug 21, 2025 | $29.48 | $30.55 | +3.63% |
May 06, 2025 | $24.02 | $25.30 | +5.33% |
Feb 19, 2025 | $21.66 | $22.82 | +5.36% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does ALK-abello A/S Class B (AKBLF) report earnings?
ALK-abello A/S Class B (AKBLF) is schdueled to report earning on Feb 05, 2026, TBA (Confirmed).
What is ALK-abello A/S Class B (AKBLF) earnings time?
ALK-abello A/S Class B (AKBLF) earnings time is at Feb 05, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is AKBLF EPS forecast?
Currently, no data Available